Human ovarian cancer stem cells

Reproduction

Volumn 140, Issue 1, 2010, Pages 33-41

  Bapat, Sharmila A ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD44V ANTIGEN; CELL SURFACE MARKER; MYELOID DIFFERENTIATION FACTOR 88; STEM CELL FACTOR RECEPTOR; HERMES ANTIGEN; TUMOR MARKER;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER STEM CELL; CANCER SURGERY; CARCINOGENESIS; CYSTADENOCARCINOMA; GERM CELL TUMOR; GRANULOSA CELL; HUMAN; MOLECULAR INTERACTION; NONHUMAN; OVARY CANCER; OVARY CARCINOMA; PRECURSOR; PRIORITY JOURNAL; REVIEW; SEX CORD TUMOR; TUMOR CELL DESTRUCTION; ADENOCARCINOMA; ANIMAL; CELL SEPARATION; FEMALE; METABOLISM; MOUSE; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD44; APOPTOSIS; CELL SEPARATION; FEMALE; HUMANS; MICE; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954196772     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-09-0389     Document Type: Review

References (73)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ & Clarke MF 2003 Prospective identification of tumorigenic breast cancer cells. PNAS 100 3983-3988. (Pubitemid 36418143)
2. Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T, Silasi DA, Steffensen KD, Waldstrom M, Visintin I et al. 2009a Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 8 158-166.
3. Alvero AB, Fu HH, Holmberg J, Visintin I, Mor L, Marquina CC, Oidtman J, Silasi DA & Mor G 2009b Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Stem Cells 27 2405-2413.
4. Alvi AJ, Clayton H, Joshi C, Enver T, Ashworth A, Vivanco MM, Dale TC & Smalley MJ 2003 Functional and molecular characterisation of mammary side population cells. Breast Cancer Research 5 R1-R8.
5. Ambler CA & Maatta A 2009 Epidermal stem cells: location, potential and contribution to cancer. Journal of Pathology 217 206-216.
6. Auersperg N, Wong AS, Choi KC, Kang SK & Leung PC 2001 Ovarian surface epithelium: biology, endocrinology, and pathology. Endocrine Reviews 22 255-288.
7. Auersperg N, Woo MM & Gilks CB 2008 The origin of ovarian carcinomas: a developmental view. Gynecologic Oncology 110 452-454.
8. Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S et al. 2009 Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 28 209-218.
9. Bapat SA, Mali AM, Koppikar CB & Kurrey NK 2005 Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Research 65 3025-3029.
10. Bast RC Jr, Hennessy B & Mills GB 2009 The biology of ovarian cancer: new opportunities for translation. Nature Reviews. Cancer 9 415-428.
11. Boring CC, Squires TS & Tong T 1993 Cancer statistics, 1993. CA: a Cancer Journal for Clinicians 43 7-26.
12. Brown PO & Palmer C 2009 The preclinical natural history of serous ovarian cancer: defining the target for early detection. PLoS Medicine 6 e1000114.
13. Bukovsky A, Caudle MR, Svetlikova M & Upadhyaya NB 2004 Origin of germ cells and formation of new primary follicles in adult human ovaries. Reproduction Biology and Endocrinology 2 20.
14. Cannistra SA, Abu-Jawdeh G, Niloff J, Strobel T, Swanson L, Andersen J & Ottensmeier C 1995 CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. Journal of Clinical Oncology 13 1912-1921.
15. Challen GA & Little MH 2006 A side order of stem cells: the SP phenotype. Stem Cells 24 3-12.
16. Chang B, Liu G, Xue F, Rosen DG, Xiao L, Wang X & Liu J 2009 ALDH1 expression correlates with favorable prognosis in ovarian cancers. Modern Pathology 22 817-823.
17. Clarke-Pearson DL 2009 Clinical practice-screening for ovarian cancer. New England Journal of Medicine 361 170-177.
18. Collins AT, Berry PA, Hyde C, Stower MJ & Maitland NJ 2005 Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research 65 10946-10951.
19. Crum CP 2009 Intercepting pelvic cancer in the distal fallopian tube: theories and realities. Molecular Oncology 3 165-170.
20. Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR et al. 2009 CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 27 2875-2883.
21. Dean M 2009 ABC transporters, drug resistance, and cancer stem cells. Journal of Mammary Gland Biology & Neoplasia 14 3-9.
22. Donnenberg VS, Meyer EM & Donnenberg AD 2009 Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells. Methods in Molecular Biology 568 261-279.
23. Ferrandina G, Bonanno G, Pierelli L, Perillo A, Procoli A, Mariotti A, Corallo M, Martinelli E, Rutella S, Paglia A et al. 2008 Expression of CD133-1 and CD133-2 in ovarian cancer. International Journal of Gynecological Cancer 18 506-514.
24. Florek M, Haase M, Marzesco AM, Freund D, Ehninger G, Huttner WB & Corbeil D 2005 Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell and Tissue Research 319 15-26.
25. Frosina G 2009 DNA repair in normal and cancer stem cells, with special reference to the central nervous system. Current Medicinal Chemistry 16 854-866.
26. Gao Q, Geng L, Kvalheim G, Gaudernack G & Suo Z 2009 Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3. Ultrastructural Pathology 33 175-181.
27. Gimenez-Bonafe P, Tortosa A & Perez-Tomas R 2009 Overcoming drug resistance by enhancing apoptosis of tumor cells. Current Cancer Drug Targets 9 320-340.
28. Goodell MA, Brose K, Paradis G, Conner AS & Mulligan RC 1996 Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. Journal of Experimental Medicine 183 1797-1806.
29. Guo Y, Kock K, Ritter CA, Chen ZS, Grube M, Jedlitschky G, Illmer T, Ayres M, Beck JF, Siegmund W et al. 2009 Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival. Clinical Cancer Research 15 1762-1769.
30. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA & Brenner MK 2004 A distinct "side population" of cells with high drug efflux capacity in human tumor cells. PNAS 101 14228-14233.
31. Kobel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A et al. 2008 Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Medicine 5 e232.
32. Kossowska-Tomaszczuk K, De Geyter C, De Geyter M, Martin I, Holzgreve W, Scherberich A & Zhang H 2009 The multipotency of luteinizing granulosa cells collected from mature ovarian follicles. Stem Cells 27 210-219.
33. Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY & Bapat SA 2009 Snail and Slug mediate radio- and chemo-resistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27 2059-2068.
34. Kusumbe AP & Bapat SA 2008 Ovarian stem cell biology and the emergence of ovarian cancer stem cells. In Cancer Stem Cells, pp 95-110. Ed. S Bapat. Hoboken, NJ: John Wiley & Sons Inc.
35. Kusumbe AP & Bapat SA 2009 Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Research 69 9245-9253.
36. Kusumbe AP, Mali AM & Bapat SA 2009 CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature. Stem Cells 27 498-508.
37. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA & Dick JE 1994 A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 645-648.
38. Lawrenson K & Gayther SA 2009 Ovarian cancer: a clinical challenge that needs some basic answers. PLoS Medicine 6 e25.
39. Lee AS, Kahatapitiya P, Kramer B, Joya JE, Hook J, Liu R, Schevzov G, Alexander IE, McCowage G, Montarras D et al. 2009 Methylguanine DNA methyltransferase-mediated drug resistance-based selective enrichment and engraftment of transplanted stem cells in skeletal muscle. Stem Cells 27 1098-1108.
40. Li C, Lee CJ & Simeone DM 2009 Identification of human pancreatic cancer stem cells. Methods in Molecular Biology 568 161-173.
41. Lin KK & Goodell MA 2006 Purification of hematopoietic stem cells using the side population. Methods in Enzymology 420 255-264.
42. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL & Yu JS 2006 Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Molecular Cancer 5 67.
43. Martin V, Xu J, Pabbisetty SK, Alonso MM, Liu D, Lee OH, Gumin J, Bhat KP, Colman H, Lang FF et al. 2009 Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters. Oncogene 28 2358-2363.
44. Mendiola M, Barriuso J, Redondo A, Marino-Enriquez A, Madero R, Espinosa E, Vara JA, Sanchez-Navarro I, Hernandez-Cortes G, Zamora P et al. 2008 Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma. PLoS ONE 3 e4051.
45. Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S & Rhim JS 2007 Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Research 67 3153-3161.
46. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK & Buck DW1997 A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90 5013-5021.
47. Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, Cavazzin C, Gritti A, Piccinini A, Porro D, Santinami M et al. 2007 Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. European Journal of Cancer 43 935-946.
48. Murph MM, Liu W, Yu S, Lu Y, Hall H, Hennessy BT, Lahad J, Schaner M, Helland A, Kristensen G et al. 2009 Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis. PLoS ONE 4 e5583.
49. O'Brien CA, Pollett A, Gallinger S & Dick JE 2007 A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 106-110.
50. Olempska M, Eisenach PA, Ammerpohl O, Ungefroren H, Fandrich F & Kalthoff H 2007 Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary & Pancreatic Diseases International 6 92-97. (Pubitemid 46243168)
51. Parrott JA, Kim G & Skinner MK 2000 Expression and action of kit ligand/stem cell factor in normal human and bovine ovarian surface epithelium and ovarian cancer. Biology of Reproduction 62 1600-1609. (Pubitemid 30333741)
52. Peinado H, Portillo F & Cano A 2004 Transcriptional regulation of cadherins during development and carcinogenesis. International Journal of Developmental Biology 48 365-375.
53. Peinado H, Olmeda D & Cano A 2007 Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nature Reviews. Cancer 7 415-428.
54. Polyak K & Weinberg RA 2009 Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Reviews. Cancer 9 265-273.
55. Reya T, Morrison SJ, Clarke MF &Weissman IL 2001 Stem cells, cancer, and cancer stem cells. Nature 414 105-111.
56. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C & De Maria R 2007 Identification and expansion of human colon-cancer- initiating cells. Nature 445 111-115.
57. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD & Dirks PB 2004 Identification of human brain tumour initiating cells. Nature 432 396-401.
58. Sotiriou C & Pusztai L 2009 Gene-expression signatures in breast cancer. New England Journal of Medicine 360 790-800.
59. Spentzos D, Levine DA, Ramoni MF, Joseph M, Gu X, Boyd J, Libermann TA & Cannistra SA 2004 Gene expression signature with independent prognostic significance in epithelial ovarian cancer. Journal of Clinical Oncology 22 4700-4710.
60. Spentzos D, Levine DA, Kolia S, Otu H, Boyd J, Libermann TA & Cannistra SA 2005 Unique gene expression profile based on pathologic response in epithelial ovarian cancer. Journal of Clinical Oncology 23 7911-7918.
61. Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C & Gottesman MM 2006 Targeting multidrug resistance in cancer. Nature Reviews. Drug Discovery 5 219-234.
62. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT & Donahoe PK 2006 Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. PNAS 103 11154-11159.
63. Szotek PP, Chang HL, Brennand K, Fujino A, Pieretti-Vanmarcke R, Lo CC, Dombkowski D, Preffer F, Cohen KS, Teixeira J et al. 2008 Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics. PNAS 105 12469-12473.
64. Tilly JL & Rueda BR 2008 Minireview: stem cell contribution to ovarian development, function, and disease. Endocrinology 149 4307-4311.
65. Tothill IE 2009 Biosensors for cancer markers diagnosis. Seminars in Cell & Developmental Biology 20 55-62.
66. Tu LC, Foltz G, Lin E, Hood L & Tian Q 2009 Targeting stem cells-clinical implications for cancer therapy. Current Stem Cell Research & Therapy 4 147-153.
67. Wani AA, Sharma N, Shouche YS & Bapat SA 2006 Nuclear-mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells. Oncogene 25 6336-6344.
68. Wikborn C, Pettersson F, Silfversward C & Moberg PJ 1993 Symptoms and diagnostic difficulties in ovarian epithelial cancer. International Journal of Gynaecology and Obstetrics 42 261-264.
69. Yahata T, Muguruma Y, Yumino S, Sheng Y, Uno T, Matsuzawa H, Ito M, Kato S, Hotta T & Ando K 2008 Quiescent human hematopoietic stem cells in the bone marrow niches organize the hierarchical structure of hematopoiesis. Stem Cells 26 3228-3236.
70. Yin S, Li J, Hu C, Chen X, Yao M, Yan M, Jiang G, Ge C, Xie H, Wan D et al. 2007 CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. International Journal of Cancer 120 1444-1450.
71. Yue Z, Jiang TX, Widelitz RB & Chuong CM 2005 Mapping stem cell activities in the feather follicle. Nature 438 1026-1029.
72. Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S, Piek E & Bottinger EP 2001 Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. PNAS 98 6686-6691.
73. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH & Nephew KP 2008 Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Research 68 4311-4320.